Loading...
Statistics
Daily Unique Visitors: 338 Daily Page Views: 1,690 Daily ad revenue potential: $ 1

About - Vivanls.com

  • Vivanls.com receives about 338 daily unique visitor.
  • Its Domain Authority is 19/100 , it's User Expectation is 9/100.
  • Its domain having .com extension.
  • According to Alexa Traffic Rank Vivanls.com is ranked number 2,144,823 in the world.
  • The domain has
  • 812 Facebook shares,
  • N/A Tweets and
  • 3 Google+.
  • The website doesn't use HTTPS protocol.
  • Vivanls.com has estimated worth of $ 843 and have a daily advertising revenue potential of around $ 1.
  • Its domain registrar is PDR LTD. D/B/A PUBLICDOMAINREGISTRY.COM.

Technology profile - Vivanls.com

Google Analytics, CSS (Cascading Style Sheets), Html (HyperText Markup Language), Html5, Iframe, Javascript, jQuery Fancybox, Php (Hypertext Preprocessor), Facebook Like box,
Last Updated: 27 Apr 2017
Vivanls.com
Source Stats
Global rank 2,144,823
Bounce Rate 91/100
Domain Authority 19/100
Server Data
IP 192.185.119.102
Latitude 29.83
Longitude -95.47
Country United States
City Houston

Featured Stats

Website User Experience: 63.6%
Website first impression (inverse bounce rate)
9 / 100
Website authority
19 / 100

Social media

Source Stats
Google +1s 3
Facebook Shares 812

Traffic Stats - vivanls.com

Unique Visitors

Daily Unique Visitors 338
Monthly unique Visitors 10,140
Unique visitors per year 123,370

Page views

Daily Page Views 1,690
Monthly page views 50,700
Page views per year 616,850

Website advertising revenue potential

Income Per Day $ 1
Income per month $ 30
Income per year $ 365

SERP preview

Drug Reference Standards| Analytical Reference Standards
www.vivanls.com/
Drug Reference Standards - "Analytical Reference Standards" products with highly characterized as well as best quality.

Readibility analysis - vivanls.com

For a good seo score, webmasters need to write a minimum 300 words (unique content!). This text content has 956 sentences and 3053 words . Congratulations. This content is huge enough to use more keywords without spamming.

Words per sentence

It has an average of 3.19 words per sentence and 2.083 syllables per word .

Readibility (Flesch–Kincaid grade)

This text content is very hard to read. It has scored a flesch reading score of 27/100 and a flesch grade of 10/100.
Here are what the scores mean:
  • 90+ An article is written for the everyday 11-year-old
  • 60-70 Easily understood by students aged 12 to 15
  • 0-30 Written for college graduates
  • n<0 Negative results are rated at 0.
Check out flesch on wikipedia to find out how it is calculated.

Technology profile - vivanls.com

Number of Web Components: 9
  • Google Analytics
  • CSS (Cascading Style Sheets)
  • Html (HyperText Markup Language)
  • Html5
  • Iframe
  • Javascript
  • jQuery Fancybox
  • Php (Hypertext Preprocessor)
  • Facebook Like box
Blocking factors:
  • Iframe

Lead & Customer generation

Clickable phone number Not Found!
Conversion form (newsletter, contact form) Not Found!
Clickable email link Found!
"Call to action" button Found!
Lists Found!
Images Found!
Enhancements Found!
Responsive layout Found!
Facebook share Found!
Google+ share Not Found!
Twitter share Not Found!
Linkedin share Not Found!
Blog Found!

HTTPS (HTTP Secure) - vivanls.com

Warning: missing HTTPS protocol.
  • Google has confirmed the ranking boost of HTTPS.
  • Secure websites are more likely to be trusted by the users and potential customers.
  • Some folks would refuse to give their email address, credit card details to unsecured websites.

    Metas

    Open Graph title:

    Vivan Life Science Pvt. Ltd.

    Open Graph description:

    Drug Reference Standards - "Analytical Reference Standards" products with highly characterized as well as best quality. ...

    Open Graph url:

    http://www.vivanls.com/

    About the domain

    Domain length: 11 characters.

    Domain is short and memorable!

    Hyphens

    Domain doesn't contain hyphens!

    Content analysis - vivanls.com

    Page title

    Drug Reference Standards| Analytical Reference Standards

    Encoding:

    UTF-8

    Other Meta tags

    • Name:
      Content: http://vivanls.com/image/cache/data/vivan_logo-200x200.png
    • Name: google-translate-customization
      Content: bbd4d0c5d532dc7-130fe793a60f68f4-g175d762a9800bcae-f
    • Name: viewport
      Content: width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=1, user-scalable=no
    • Name: format-detection
      Content: telephone=no
    • Name: description
      Content: Drug Reference Standards - "Analytical Reference Standards" products with highly characterized as well as best quality.

    Word weight (top 20)

    • drug 36
    • with 27
    • life 20
    • 2015 20
    • fda 19
    • rappelling 18
    • waterfall 18
    • trekking 18
    • sciences 17
    • research 16
    • vivan 16
    • treatment 15
    • new 14
    • based 12
    • cancer 12
    • patients 12
    • pharma 12
    • administration 12
    • global 12
    • food 11
    • india 11
    • standards 10
    • company 10
    • its 10
    • tablets 10
    • pharmaceutical 9
    • reference 9
    • approval 9
    • market 8
    • products 8

    Word density (top 20)

    • drug 35
    • with 27
    • life 20
    • fda 19
    • sciences 17
    • research 16
    • vivan 16
    • treatment 15
    • new 14
    • global 12
    • cancer 12
    • based 12
    • patients 12
    • pharma 12
    • administration 12
    • india 11
    • food 11
    • company 10
    • tablets 10
    • its 10
    • pharmaceutical 9
    • approval 9
    • market 8
    • products 8
    • healthcare 7
    • business 7
    • industry 7
    • announced 7
    • merck 7
    • generic 7

    Occurence of top 3 keywords.

    drugwithlife
    Domain name
    Meta title1
    Meta description11
    H1 tags1
    H2 tags1
    H3 tags21
    Bold, strong text623318
    Italic text
    Image names
    Image alt texts1
    Link urls1297
    Link texts

    Headings (H tags) - vivanls.com

    <H1> <H2> <H3> <H4> <H5> <H6>
    1 1 42 0 0 0

    H1 content:

    • Drug Reference Standards| Analytical Reference Standards

    H2 content:

    • Welcome to VIVAN Life Sciences

    H3 content:

    • About Us
    • Our Vision
    • IPR Practices
    • VIVAN & Logo
    • Business Units
    • Photo Gallery
    • Safety & Environment
    • Neurons
    • Mission
    • Corporate Strategy
    • Culture & Values
    • Support Network
    • Corporate Governance
    • Social Responsibility
    • R & D Center
    • Analytical Labs
    • Why VIVAN
    • Working With VIVAN
    • How We Work
    • Careers @ VIVAN
    • Work Practice & Ethics
    • Internship @ VIVAN
    • Our Culture
    • Alumni Network
    • Leadership In Making
    • Moments Of Joy
    • Work Life Balance
    • CRISIL Verified
    • NSIC-CRISIL MSE Ratings
    • CRISIL- SME Ratings
    • D&B D-U-N-S Number
    • LAYA
    • SHRUTI
    • Social Responsibility
    • Feedback
    • Reach Us
    • Partner With Us
    • About Us
    • Customer Support
    • Contact Us
    • Like us on Facebook
    • Newsletter
    Number of strong texts: 328
    Number of bold texts: 2
    Number of anchor texts: 193

    Text content

    Character count: 21406

    The page's content of more than 3000 characters!

    Text/Image Ratio

    On average, there is one image per every 54 words.

    Images

    Number of images: 49
    Number of missing "alt" attributes: 31
    • Source: vivanls . com / image / cache / data / vivan_logo-273x73 . png
      Alt: Vivan Life Science Pvt . Ltd .
    • Source: vivanls . com / image / data / laya-csrlogo . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / data / shruti-csrlogo . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / data / qc2 . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / 21 . 04 . / levomefloate d4-50x50h . jpg
      Alt: Levomefolate D4
    • Source: vivanls . com / image / cache / data / 21 . 04 . / amoxicillin d4-50x50h . jpg
      Alt: Amoxicillin d4
    • Source: vivanls . com / image / cache / data / 12 . 4 . 2017 / Quinine-d3-50x50h . jpg
      Alt: Quinine-d3
    • Source: vivanls . com / image / data / enqu . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / data / login . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / data / csr . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / data / pay1 . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / gallery / 2016 / 1-2016-200x200h . png
      Alt: Waterfall Rappelling and Trekking : 2015
    • Source: vivanls . com / image / cache / data / gallery / 2016 / 4-2016-200x200h . png
      Alt: Waterfall Rappelling and Trekking : 2015
    • Source: vivanls . com / image / cache / data / gallery / 2016 / 5-2016-200x200h . png
      Alt: Waterfall Rappelling and Trekking : 2015
    • Source: vivanls . com / image / cache / data / gallery / 2016 / 6-2016-200x200h . png
      Alt: Waterfall Rappelling and Trekking : 2015
    • Source: vivanls . com / image / cache / data / gallery / 2016 / 5-2016-200x200h . png
      Alt: Waterfall Rappelling and Trekking : 2015
    • Source: vivanls . com / image / cache / data / gallery / 2016 / 2-2016-200x200h . png
      Alt: Waterfall Rappelling and Trekking : 2015
    • Source: vivanls . com / image / cache / data / gallery / right gallery img / 12-200x200h . jpg
      Alt: Waterfall Rappelling and Trekking : 2015
    • Source: vivanls . com / image / cache / data / gallery / 2016 / 8-2016-200x200h . png
      Alt: Waterfall Rappelling and Trekking : 2015
    • Source: vivanls . com / image / cache / data / gallery / 2016 / 9-2016-200x200h . png
      Alt: Waterfall Rappelling and Trekking : 2015
    • Source: vivanls . com / image / cache / data / journal2 / transparent-980x400 . png
      Alt: 1
    • Source: vivanls . com / image / cache / data / journal2 / transparent-980x400 . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / journal2 / transparent-980x400 . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / journal2 / transparent-980x400 . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / journal2 / transparent-980x400 . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / journal2 / transparent-980x400 . png
      Alt: missing alt attribute!
    • Source: image / master . jpg
      Alt: missing alt attribute!
    • Source: image / visa . jpg
      Alt: missing alt attribute!
    • Source: image / am-ex . jpg
      Alt: missing alt attribute!
    • Source: image / fedex . jpg
      Alt: missing alt attribute!
    • Source: image / dhl . jpg
      Alt: missing alt attribute!
    • Source: image / ups . png
      Alt: missing alt attribute!
    • Source: image / bluedart . jpg
      Alt: missing alt attribute!
    • Source: image / EN . jpg
      Alt: missing alt attribute!
    • Source: image / ship . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / data / crisil . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / data / VIVANMSELogo . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / data / VIVANSMElogo . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / data / vivan_logo1-300x50 . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / data / gallery / blog / Click-Here-Button . png
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / vivan_foundation / new-human-touch-logo-2104-180x180 . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / vivan_foundation / endura_plus_box-180x180 . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / vivan_foundation / new-neurons-logo-2014-180x180 . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / vivan_foundation / VIVAN's-new-Logo-180x180 . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / vivan_foundation / new-vivan-direct-logo-2014-180x180 . jpg
      Alt: missing alt attribute!
    • Source: vivanls . com / image / cache / data / journal2 / transparent-50x31 . png
      Alt: Visa
    • Source: vivanls . com / image / cache / data / journal2 / transparent-50x31 . png
      Alt: PayPal
    • Source: vivanls . com / image / cache / data / journal2 / transparent-50x31 . png
      Alt: Master Card
    • Source: vivanls . com / image / cache / data / journal2 / transparent-50x31 . png
      Alt: American Express
    Make sure the alt texts include your SEO keywords and relate to / describe the image.

    Text/Link Ratio

    On average, there is one link per every 16 words.

    Text links

    Number of links: 164
    • Href: http://vivanls.com/index.php?route=account/login
      Text: Login
    • Href: http://vivanls.com/index.php?route=account/register
      Text: Register
    • Href: http://vivanls.com/index.php?route=account/wishlist
      Text: Wish List (0)
    • Href: http://vivanls.com/about-us
      Text: About Us
    • Href: http://vivanls.com/our-vision
      Text: Our Vision
    • Href: http://vivanls.com/ipr-practices
      Text: IPR Practices
    • Href: http://vivanls.com/vivan-and-logo
      Text: VIVAN & Logo
    • Href: http://vivanls.com/business-units
      Text: Business Units
    • Href: index.php?route=line/gallery
      Text: Photo Gallery
    • Href: http://vivanls.com/safety-amp-environment-protection-policy
      Text: Safety & Environment
    • Href: http://vivanls.com/neurons
      Text: Neurons
    • Href: http://vivanls.com/corporate-governance
      Text: Corporate
    • Href: http://vivanls.com/our-mission
      Text: Mission
    • Href: http://vivanls.com/corporate-strategy
      Text: Corporate Strategy
    • Href: http://vivanls.com/culture-and-values
      Text: Culture & Values
    • Href: http://vivanls.com/support-network
      Text: Support Network
    • Href: http://vivanls.com/corporate-governance
      Text: Corporate Governance
    • Href: http://vivanls.com/vivan-s-csr
      Text: Social Responsibility
    • Href: http://vivanls.com/products
      Text: Products
    • Href: http://vivanls.com/clinical-diagnostic-r-amp-d-center
      Text: R & D Center
    • Href: http://vivanls.com/deuterated-internal-standard-analytical-labs
      Text: Analytical Labs
    • Href: http://vivanls.com/careers-at-vivan-bio-availability-and-bio-equivalence-clinical-trial-ba-be-studies
      Text: Careers
    • Href: http://vivanls.com/index.php?route=information/information&information_id=23
      Text: Why VIVAN
    • Href: http://vivanls.com/working-with-vivan
      Text: Working With VIVAN
    • Href: http://vivanls.com/how-we-work
      Text: How We Work
    • Href: http://vivanls.com/careers-at-vivan-bio-availability-and-bio-equivalence-clinical-trial-ba-be-studies
      Text: Careers @ VIVAN
    • Href: http://vivanls.com/work-practice-amp-ethics
      Text: Work Practice & Ethics
    • Href: http://vivanls.com/bio-availability-and-bio-equivalence-clinical-trial-ba-be-studies
      Text: Internship @ VIVAN
    • Href: http://vivanls.com/our-culture
      Text: Our Culture
    • Href: http://vivanls.com/alumni-network
      Text: Alumni Network
    • Href: http://vivanls.com/leadership-in-making
      Text: Leadership In Making
    • Href: index.php?route=line/gallery
      Text: Moments Of Joy
    • Href: http://vivanls.com/work-life-balance
      Text: Work Life Balance
    • Href: http://vivanls.com/crisil-verified
      Text: CRISIL Verified
    • Href: http://vivanls.com/crisil-sme-ratings
      Text: NSIC-CRISIL MSE Ratings
    • Href: http://vivanls.com/crisil-is-a-global-analytical-company
      Text: CRISIL- SME Ratings
    • Href: http://vivanls.com/d-amp-b-d-u-n-s-number
      Text: D&B D-U-N-S Number
    • Href: http://vivanls.com/vivan-s-csr
      Text: VIVAN's CSR
    • Href: http://vivanls.com/index.php?route=information/information&information_id=47
      Text: -> Child Labor & Education
    • Href: http://vivanls.com/index.php?route=information/information&information_id=48
      Text: -> Grow Trees
    • Href: http://vivanls.com/index.php?route=information/information&information_id=49
      Text: -> Re- Think
    • Href: http://vivanls.com/index.php?route=information/information&information_id=50
      Text: -> Reduce your Trash
    • Href: http://vivanls.com/index.php?route=information/information&information_id=51
      Text: -> Save Energy Save Electricity
    • Href: http://vivanls.com/index.php?route=information/information&information_id=52
      Text: -> Save paper Save trees
    • Href: http://vivanls.com/index.php?route=information/information&information_id=53
      Text: -> Save water save life
    • Href: http://vivanls.com/index.php?route=information/information&information_id=54
      Text: -> Things one must know
    • Href: http://vivanls.com/contact-us
      Text: Contact Us
    • Href: http://www.vivanls.com
      Text: http://www.vivanls.com
    • Href: mailto:info@vivanls.com
      Text: info@vivanls.com
    • Href: http://blog.vivanls.com/
      Text: Blog
    • Href: http://vivanls.com/drug-reference-standards
      Text: Drug Reference Standards : VIVAN Life Sciences
    • Href: http://vivanls.com/deuterium-labeled-compounds
      Text: Deuterium Labeled Compounds
    • Href: http://vivanls.com/metabolites
      Text: LC-MS/MS Method Validation| Metabolites
    • Href: http://vivanls.com/drug-impurities
      Text: Impurities | Quantitative Bioanalytical Methods
    • Href: http://vivanls.com/glucuronides
      Text: Glucuronides | HPLC-MS/MS Method Validation
    • Href: http://vivanls.com/chiral-standards
      Text: Chiral Standards
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=
      Text:   #  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=A
      Text:   A  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=B
      Text:   B  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=C
      Text:   C  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=D
      Text:   D  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=E
      Text:   E  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=F
      Text:   F  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=G
      Text:   G  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=H
      Text:   H  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=I
      Text:   I  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=J
      Text:   J  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=K
      Text:   K  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=L
      Text:   L  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=M
      Text:   M  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=N
      Text:   N  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=O
      Text:   O  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=P
      Text:   P  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=Q
      Text:   Q  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=R
      Text:   R  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=S
      Text:   S  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=T
      Text:   T  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=U
      Text:   U  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=V
      Text:   V  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=W
      Text:   W  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=X
      Text:   X  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=Y
      Text:   Y  
    • Href: http://vivanls.com/index.php?route=product/AlphabeticallyProducts&char=Z
      Text:   Z  
    • Href: http://vivanls.com/levomefolate-d4
      Text:
    • Href: http://vivanls.com/levomefolate-d4
      Text: Levomefolate D4
    • Href: http://vivanls.com/amoxicillin-d4
      Text:
    • Href: http://vivanls.com/amoxicillin-d4
      Text: Amoxicillin d4
    • Href: http://vivanls.com/quinine-d3
      Text:
    • Href: http://vivanls.com/quinine-d3
      Text: Quinine-d3
    • Href: http://vivanls.com/image/cache/data/gallery/2016/1-2016-700x394.png
      Text:
    • Href: http://vivanls.com/image/cache/data/gallery/2016/4-2016-700x394.png
      Text:
    • Href: http://vivanls.com/image/cache/data/gallery/2016/5-2016-700x394.png
      Text:
    • Href: http://vivanls.com/image/cache/data/gallery/2016/6-2016-700x394.png
      Text:
    • Href: http://vivanls.com/image/cache/data/gallery/2016/5-2016-700x394.png
      Text:
    • Href: http://vivanls.com/image/cache/data/gallery/2016/2-2016-700x394.png
      Text:
    • Href: http://vivanls.com/image/cache/data/gallery/right gallery img/12-700x394.jpg
      Text:
    • Href: http://vivanls.com/image/cache/data/gallery/2016/8-2016-700x394.png
      Text:
    • Href: http://vivanls.com/image/cache/data/gallery/2016/9-2016-700x394.png
      Text:
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=101635&sid=2
      Text: GE partners with USAID for India's Healthcare needs
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=101598&sid=1
      Text: Telangana-‘Bulk drug manufacturing hub of India'
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=101505&sid=2
      Text: Amgen launches online media resource
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=101475&sid=2
      Text: Allergan collaborates with Novartis
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=101406&sid=2
      Text: Phagelux collaborates with Johnson & Johnson
    • Href: http://profit.ndtv.com/news/your-money/article-fmcg-highest-paying-industry-with-average-pay-of-rs-11-lakh-survey-1678204
      Text: Survey brings FMCG as the highest paying industry
    • Href: http://www.businesstoday.in/sectors/pharma/cipla-bets-respiratory-oncology-and-hiv-segments-brazil-china/story/246961.html
      Text: Cipla bets on respiratory, oncology and HIV segments in Brazil and China
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=101222&sid=2
      Text: Cipla receives final approval for generic Epzicom tablets
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=101112&sid=1
      Text: India & Netherlands to begin a Research
    • Href: http://www.businesstoday.in/sectors/pharma/abbott-to-make-india-hub-of-global-research-and-development-for-branded-generics/story/244621.html
      Text: Abbott to make India hub of global research and development for branded generics
    • Href: http://www.businesstoday.in/sectors/pharma/lupin-gets-usfda-nod-to-market-cancer-drug/story/247096.html
      Text: Alembic Pharma's partner launches drug for depressive disorder
    • Href: http://www.pharmatimes.com/news/boehringer_signs_copd_research_deal_with_weill_1186847
      Text: Boehringer signs COPD research deal with Weill
    • Href: http://www.nanhikali.org/in-the-news/in-the-news-details.aspx?id=9056
      Text: Project Nanhi Kali at the Standard Chartered Mumbai Marathon, 2017
    • Href: http://www.outsourcing-pharma.com/Clinical-Development/Pharm-Olam-nabs-PE-investment-amid-market-void-for-mid-tier-CROs
      Text: Pharm-Olam nabs PE investment amid 'market void' for mid-tier CROs
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=100224&sid=2
      Text: US FDA accepts Intarcia's NDA for ITCA 650 to treat type 2 diabetes
    • Href: http://www.outsourcing-pharma.com/Commercial-Services/Almac-launches-TempEZ-temperature-management-software
      Text: Almac launches temperature management software
    • Href: http://www.in-pharmatechnologist.com/Regulatory-Safety/Cannabis-grower-gains-EMA-GMP-status-for-Dutch-plants
      Text: GMP-status 'a major step' for medical marijuana recognition, Bedrocan
    • Href: http://www.in-pharmatechnologist.com/Regulatory-Safety/Trump-names-Robert-F.-Kennedy-Jr-to-vaccine-commission
      Text: Trump names chair of vaccine commission to examine 'scientific integrity';
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=99628&sid=2
      Text: Bayer's regorafenib receives US FDA Priority Review status for second-line treatment of liver cancer;
    • Href: http://www.businesstoday.in/sectors/pharma/indian-pharma-industry-facing-growth-headwinds-icra/story/241983.html
      Text: Indian pharma industry facing growth headwinds;
    • Href: http://www.fiercepharma.com/vaccines/parker-institute-cancer-research-institute-team-up-to-develop-cancer-vaccines
      Text: Parker Institute, Cancer Research Institute team up on neoantigen-based cancer vaccines;
    • Href: http://www.worldpharmanews.com/research/3706-greater-efforts-are-needed-to-encourage-patients-to-report-adverse-drug-reactions
      Text: Greater efforts are needed to encourage patients to report adverse drug reactions;
    • Href: http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-amabelz-tablets-in-us-market/articleshow/55439186.cms
      Text: Lupin launches Amabelz tablets in US market;
    • Href: http://timesofindia.indiatimes.com/city/nashik/FDA-to-crack-whip-on-pharma-companies/articleshow/55344029.cms
      Text: FDA to crack whip on pharma companies;
    • Href: http://www.pharmatimes.com/news/eisai_kicks_off_mid-stage_study_of_sleep_drug_1175910
      Text: Eisai kicks off mid-stage study of sleep drug;
    • Href: https://www.drugs.com/news/old-blood-good-new-transfusions-study-finds-63165.html
      Text: Using the freshest blood for transfusions does not appear to boost patient survival, a new Canadian study indicates.;
    • Href: https://www.drugs.com/newdrugs/fda-grants-accelerated-approval-lartruvo-olaratumab-advanced-soft-tissue-sarcoma-4446.html
      Text: FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma;
    • Href: http://www.fiercepharma.com/manufacturing/chinese-api-makers-look-to-move-up-value-chain
      Text: Chinese API makers look to move up the value chain;
    • Href: http://www.fiercepharma.com/vaccines/sanofi-grabs-43m-u-s-government-funds-for-zika-vaccine-r-d
      Text: Sanofi grabs $43M in U.S. government funds to advance Zika vaccine into Phase II;
    • Href: http://www.business-standard.com/article/markets/chart-check-power-grid-pidilite-bharat-financial-aurobindo-pharma-116090700128_1.html
      Text: Power Grid, Pidilite, Bharat Financial, Aurobindo Pharma.;
    • Href: http://www.businesstoday.in/sectors/pharma/now-a-paper-based-device-can-spot-poor-quality-medicines/story/236379.html
      Text: Now, a paper-based device can spot poor-quality medicines;
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=96908&sid=2
      Text: HarlePhil Ventures to market Biocept's liquid biopsy tests in Philippines;
    • Href: http://www.pharmabiz.com/NewsDetails.aspx?aid=96641&sid=2
      Text: Cipla appoints Kedar Upadhye as global CFO;
    • Href: http://www.worldofchemicals.com/media/fmc-elects-current-director-as-new-vice-president/10191.html
      Text: FMC elects current director as new vice president >
    • Href: http://drugdelivery.pharmaceutical-business-review.com/news/globaldata-expects-ipf-market-to-more-than-treble-to-32bn-by-2025-220616-4930247
      Text: GlobalData expects IPF market to more than treble to $3.2bn by 2025 >
    • Href: http://www.worldpharmanews.com/merckgroup/3514-merck-in-agreement-with-happyneuron-to-offer-first-of-its-kind-e-health-solution-for-people-living-with-multiple-sclerosis
      Text: Merck, a leading science and technology company, announced today that the company has entered into an agreement with HAPPYneuron, >
    • Href: http://www.worldpharmanews.com/boehringer-ingelheim/3497-boehringer-ingelheim-increases-access-to-the-medication-for-the-treatment-of-hiv-aids
      Text: Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Rizatriptan Benzoate Orally Disintegrating Tablets, 5 mg and 10 mg, the generic version of Maxalt-MLT Orally Disintegrating, 5 mg and 10 mg Tablets (of Merck), which is indicated for the acute treatment of migraine in adults and in pediatric patients;
    • Href: http://www.worldpharmanews.com/boehringer-ingelheim/3497-boehringer-ingelheim-increases-access-to-the-medication-for-the-treatment-of-hiv-aids
      Text: Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Rizatriptan Benzoate Orally Disintegrating Tablets, 5 mg and 10 mg, the generic version of Maxalt-MLT Orally Disintegrating, 5 mg and 10 mg Tablets (of Merck), which is indicated for the acute treatment of migraine in adults and in pediatric patients;
    • Href: http://www.moneycontrol.com/news/buzzing-stocks/sms-pharma-rises-12usfda-nod-for-andhra-pradesh-plant_4754061.html
      Text: GlaxoSmithKline (GSK) has agreed to acquire Bristol-Myers Squibb's (BMS) pipeline of research and development (R&D) HIV assetsfor about $1.5bn;
    • Href: http://www.moneycontrol.com/news/buzzing-stocks/sms-pharma-rises-12usfda-nod-for-andhra-pradesh-plant_4754061.html
      Text: Teva wins approval for COPAXONE to prevent relapse of multiple sclerosis............ 
    • Href: http://regulatoryaffairs.pharmaceutical-business-review.com/news/teva-wins-approval-for-copaxone-to-prevent-relapse-of-multiple-sclerosis
      Text: The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Teva Pharmaceutical Industries' once-daily COPAXONE (glatiramer acetate injection) 20mg injection for the prevention of relapse of multiple sclerosis;
    • Href: http://processandproduction.pharmaceutical-business-review.com/news/nice-recommends-bristol-myers-squibbs-daklinza-to-treat-chronic-hepatitis-c-virus-infection
      Text: Bristol-Myers Squibb announced that the National Institute for Health and Care Excellence (NICE) has recommended Daklinza (daclatasvir) in England and Wales for the treatment of adult patients with chronic hepatitis C virus (HCV) infection;
    • Href: http://regulatoryaffairs.pharmaceutical-business-review.com/news/jubilant-life-sciences-wins-anda-approval-for-rizatriptan-benzoate-od-tablets
      Text: Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Rizatriptan Benzoate Orally Disintegrating Tablets, 5 mg and 10 mg, the generic version of Maxalt-MLT Orally Disintegrating, 5 mg and 10 mg Tablets (of Merck), which is indicated for the acute treatment of migraine in adults and in pediatric patients;
    • Href: http://regulatoryaffairs.pharmaceutical-business-review.com/news/fda-approves-merrimacks-metastatic-pancreatic-cancer-drug
      Text: The US Food and Drug Administration (FDA) has approved Merrimack Pharmaceuticals’ metastatic pancreatic cancer drug, Onivyde;
    • Href: http://clinicaltrials.pharmaceutical-business-review.com/news/worlds-largest-aspirin-anti-cancer-trial-launches-in-uk
      Text: The world's largest clinical trial to see whether taking a daily dose of aspirin can stop cancer from recurring has been launched in the UK;
    • Href: http://www.outsourcing-pharma.com/Clinical-Development/Pfizer-Allergan-deal-report-prompts-speculation-about-fallout-for-CROs
      Text: Reports Pfizer is considering buying Allergan to create a company worth $330bn have once again raised fears of disruption for contract research organisations (CRO), although there are reasons to think the deal would be less troublesome than earlier megamergers;
    • Href: http://www.outsourcing-pharma.com/Commercial-Services/Hanson-Shimadzu-combine-techs-to-create-an-automated-testing-system
      Text: Hanson Research and Shimadzu have teamed up to combine their respective technologies into an automated online pharmaceutical testing system;
    • Href: http://itsoftware.pharmaceutical-business-review.com/news/hvivo-invests-in-prep-biopharm
      Text: hVIVO has made an investment in the UK-based start-up, PrEP Biopharm, to further develop new prophylactic treatment for respiratory infections;
    • Href: http://contractservices.pharmaceutical-business-review.com/news/tara-immuno-oncology-acquires-licenses-to-develop-clinical-stage-p53mva-oncology-vaccine
      Text: Tara Immuno-Oncology has acquired licenses from City of Hope for the development of p53MVA (modified vaccinia ankara) and a Salmonella-based therapy targeting Indoleamine 2,3-Dioxygenase (shIDO-ST), both for multiple oncology indication;
    • Href: http://regulatoryaffairs.pharmaceutical-business-review.com/news/fda-approves-gilead-sciences-genvoya-hiv-drug
      Text: The US Food and Drug Administration (FDA) has approved Gilead Sciences' Genvoya HIV drug to treat patients aged 12 and above;
    • Href: http://otc.pharmaceutical-business-review.com/news/leo-pharma-to-buy-astellas-pharmas-global-dermatology-portfolio
      Text: LEO Pharma has agreed to acquire Astellas Pharma's global dermatology business for €675m;
    • Href: http://manufacturing.pharmaceutical-business-review.com/news/emerson-ge-healthcare-partner-to-increase-biopharma-manufacturing-efficiency
      Text: Emerson Process Management has partnered with GE Healthcare’s Life Sciences business to increase productivity and improve efficiency in the production of biopharmaceuticals;
    • Href: http://contractservices.pharmaceutical-business-review.com/news/astrazeneca-agrees-to-sell-us-rights-for-entocort-drug-to-perrigo
      Text: AstraZeneca has agreed to sell the US rights for its gastrointestinal drug Entocort to Perrigo for $380m;
    • Href: http://www.in-pharmatechnologist.com/Processing/Acquired-Sigma-Aldrich-businesses-part-of-Merck-s-Africa-growth-plan
      Text: New acquisition Sigma Aldrich will play a part in African growth plans in addition to giving it a presence in the preclinical services sector says Merck;
    • Href: #carousel-288086604-0
      Text: How To Order
    • Href: #carousel-288086604-1
      Text: How To Pay
    • Href: #carousel-288086604-2
      Text: Products Dispatch
    • Href: http://vivanls.com/vivan-s-csr
      Text:
    • Href: http://vivanls.com/index.php?route=information/information&information_id=56
      Text:
    • Href: http://vivanls.com/index.php?route=information/information&information_id=55
      Text:
    • Href: http://vivanls.com/index.php?route=information/information&information_id=11
      Text:
    • Href: http://vivanls.com/index.php?route=information/information&information_id=46
      Text:
    • Href: index.php?route=information/information&information_id=4
      Text: -Read More
    • Href: http://vivanls.com/privacy-policy-2
      Text: Privacy Policy
    • Href: http://vivanls.com/disclaimer
      Text: Disclaimer
    • Href: http://vivanls.com/index.php?route=information/sitemap
      Text: Site Map

    Scripts

    Number of javascripts: 7
    • http://vivanls.com/journal-cache/_d1315b73370eeefb015b1fc2aacf837b.js
    • //translate.google.com/translate_a/element.js?cb=googleTranslateElementInit
    • catalog/view/theme/journal2/fancybox/jquery.fancybox.js
    • catalog/view/theme/journal2/fancybox/jquery.fancybox.pack.js
    • catalog/view/javascript/ajaxsearch.js
    • http://xslt.alexa.com/site_stats/js/t/a?url=vivanls.com
    • http://vivanls.com/journal-cache/_8714235b2705446824c8c841de80f4e6.js
    Too much javascript can harm rankings and might confuse the search engines.

    Web server

    Host IP Address
    ns1.xpresshosting.co.in 192.185.118.8
    ns2.xpresshosting.co.in 192.185.118.80

    HTTP Header Response

    HTTP/1.1 200 OK Server: nginx/1.12.0 Date: Thu, 27 Apr 2017 08:01:19 GMT Content-Type: text/html; charset=utf-8 Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Set-Cookie: PHPSESSID=f1223a0584660d2d889d264b90a89bdb; path=/; HttpOnly Set-Cookie: language=en; expires=Sat, 27-May-2017 08:01:19 GMT; path=/; domain=www.vivanls.com Set-Cookie: currency=USD; expires=Sat, 27-May-2017 08:01:19 GMT; path=/; domain=www.vivanls.com X-Cache: MISS from chicago01.highproxies.com X-Cache-Lookup: MISS from chicago01.highproxies.com:3128 Transfer-Encoding: chunked Connection: keep-alive

    DNS

    host: vivanls.com
    1. class: IN
    2. ttl: 14387
    3. type: A
    4. ip: 192.185.119.102
    host: vivanls.com
    1. class: IN
    2. ttl: 86400
    3. type: NS
    4. target: ns1.xpresshosting.co.in
    host: vivanls.com
    1. class: IN
    2. ttl: 86400
    3. type: NS
    4. target: ns2.xpresshosting.co.in
    host: vivanls.com
    1. class: IN
    2. ttl: 86400
    3. type: SOA
    4. mname: ns1.xpresshosting.co.in
    5. rname: mhatred.gmail.com
    6. serial: 2017012100
    7. refresh: 86400
    8. retry: 7200
    9. expire: 3600000
    10. minimum-ttl: 86400
    host: vivanls.com
    1. class: IN
    2. ttl: 14400
    3. type: MX
    4. pri: 0
    5. target: bmx1.emailscanner.co.in
    host: vivanls.com
    1. class: IN
    2. ttl: 14400
    3. type: TXT
    4. txt: v=spf1 ip4:184.173.239.120 a mx include:websitewelcome.com ~all
    5. entries: Array

    Domain

    Domain Registrar: PDR LTD. D/B/A PUBLICDOMAINREGISTRY.COM
    Registration Date: 2010-03-05 7 years, 7 months & 21 days ago
    Last Updated: 2015-04-03 2 years, 6 months & 21 days ago
    Expiration Date: 2024-03-05 6 years, 4 months & 18 days left

    vivanls.com whois

    		
    vivanls.com domain lookup results from whois.PublicDomainRegistry.com server:
    
    Domain Name: VIVANLS.COM
    Registry Domain ID: 1595488009_DOMAIN_COM-VRSN
    Registrar WHOIS Server: whois.publicdomainregistry.com
    Registrar URL: www.publicdomainregistry.com
    Updated Date: 2015-11-07T03:06:15Z
    Creation Date: 2010-05-03T12:06:43Z
    Registrar Registration Expiration Date: 2024-05-03T12:06:43Z
    Registrar: PDR Ltd. d/b/a PublicDomainRegistry.com
    Registrar IANA ID: 303
    Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
    Registry Admin ID: Not Available From Registry
    Admin Organization: VIVAN Life Sciences Pvt. Limited.
    Admin Street: 511, Lodha Supremus, Road No. 22, Wagle Industrial Estate,
    Admin City: Thane (W)
    Admin State/Province: Maharashtra
    Admin Postal Code: 400604
    Admin Country: IN
    Admin Fax:
    Admin Fax Ext:
    Registry Tech ID: Not Available From Registry
    Tech Organization: VIVAN Life Sciences Pvt. Limited.
    Tech Street: 511, Lodha Supremus, Road No. 22, Wagle Industrial Estate,
    Tech City: Thane (W)
    Tech State/Province: Maharashtra
    Tech Postal Code: 400604
    Tech Country: IN
    Tech Fax:
    Tech Fax Ext:
    Name Server: ns1.xpresshosting.co.in
    Name Server: ns2.xpresshosting.co.in
    DNSSEC:Unsigned
    URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
    >>> Last update of WHOIS database: 2017-04-27T08:01:29Z 
    

    Tping errors

    Typing errors at searches for Vivanls.com.

    ivanls.com vivanls.com ivanls.com vcivanls.com civanls.com vdivanls.com divanls.com vfivanls.com fivanls.com vgivanls.com givanls.com vbivanls.com bivanls.com v ivanls.com ivanls.com vvanls.com viuvanls.com vuvanls.com vijvanls.com vjvanls.com vikvanls.com vkvanls.com vilvanls.com vlvanls.com viovanls.com vovanls.com vi8vanls.com v8vanls.com vi9vanls.com v9vanls.com vi*vanls.com v*vanls.com vianls.com vivanls.com vianls.com vivcanls.com vicanls.com vivdanls.com vidanls.com vivfanls.com vifanls.com vivganls.com viganls.com vivbanls.com vibanls.com viv anls.com vi anls.com vivnls.com vivaqnls.com vivqnls.com vivawnls.com vivwnls.com vivaznls.com vivznls.com vivaxnls.com vivxnls.com vivasnls.com vivsnls.com vivals.com vivanbls.com vivabls.com vivangls.com vivagls.com vivanhls.com vivahls.com vivanjls.com vivajls.com vivanmls.com vivamls.com vivan ls.com viva ls.com vivans.com vivanlps.com vivanps.com vivanlos.com vivanos.com vivanlis.com vivanis.com vivanlks.com vivanks.com vivanlms.com vivanms.com vivanl.s.com vivan.s.com vivanl.com vivanlsq.com vivanlq.com vivanlsw.com vivanlw.com vivanlse.com vivanle.com vivanlsz.com vivanlz.com vivanlsx.com vivanlx.com vivanlsc.com vivanlc.com vivanls.comn vivanls.con vivanls.comh vivanls.coh vivanls.comj vivanls.coj vivanls.comk vivanls.cok vivanls.coml vivanls.col vivanls.com vivanls.co vivanls.coim vivanls.cim vivanls.cokm vivanls.ckm vivanls.colm vivanls.clm vivanls.copm vivanls.cpm vivanls.co9m vivanls.c9m vivanls.co0m vivanls.c0m vivanls.cxom vivanls.xom vivanls.csom vivanls.som vivanls.cdom vivanls.dom vivanls.cfom vivanls.fom vivanls.cvom vivanls.vom vivanls.c om vivanls. om


    Review URL: Short desc:
    Vivanls.com receives about 338 daily visitor. Its Domain Authority is 19/100. Its Alexa Rank is 2,144,823 in the world." />
    Long desc:
    Vivanls.com receives about 338 daily unique visitor. Its DA is 19/100. It has global traffic rank #2,144,823. Its domain having .com extension. Vivanls.com has estimated worth of $ 843 and have a daily advertising revenue potential of around $ 1.
    Reviewed domain:
    Vivanls.com
    Date published: 2017-04-27 08:01:41
    Rating:
    3.18 / 5 stars

    Vivanls.com review

    Vivanls.com receives about 338 daily visitor. Its Domain Authority is 19/100. Its Alexa Rank is 2,144,823 in the world." />